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Abstract
Background: Diseases of the kidneys and genitourinary tract are common health problems that affect people of all ages and
demographic backgrounds. In this study, we compared the quantity and quality of nephrological and urological articles
published in international journals from the three major regions of China: the mainland (ML), Hong Kong (HK), and Taiwan
(TW).
Methods: Nephrological and urological articles originating from ML, TW, and HK that were published in 61 journals from
1999–2008 were retrieved from the PubMed database. We recorded the numbers of total articles, clinical trials, randomized
controlled trials, case reports, impact factors (IF), citations, and articles published in the leading general-medicine journals.
We used these data to compare the quantity and quality of publication output from the three regions.
Results: The total number of articles increased significantly from 1999 to 2008 in the three regions. The number of articles
from ML has exceeded that from HK since 2004, and surpassed that from TW in 2008. Publications from TW had the highest
accumulated IF, total citations of articles, and the most articles published in leading general-medicine journals. However, HK
publications had the highest average IF. Although ML produced the largest quantity of articles, it exhibited the lowest
quality among the three regions.
Conclusion: The number of nephrological and urological publications originating from the three major regions of China
increased significantly from 1999 to 2008. The annual number of publications by ML researchers exceeded those from TW
and HK. However, the quality of articles from TW and HK was higher than that from ML.
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Introduction
Diseases of the kidneys and genitourinary tract are common
health problems that affect people of all ages and demographic
backgrounds. The increasing incidence and prevalence of chronic
kidney disease (CKD) have become a global public health challenge
[1]. The screening of 6311 adult (.20 years old) residents of
southern China found albuminuria, hematuria, and reduced
estimated glomerular filtration rates (eGFR) in 6.6%, 3.8%, and
3.2% of participants, respectively [2]. Chronic glomerulonephritis,
usually caused by primary glomerular disease, constituted the
leading cause of end-stage renal failure (ESRD) in China, followed
by diabetic and hypertensive nephropathies [3]. The annual rate of
dialysis in Mainland China was 79.1 per million people (pmp) in
2008 [4]. Renal replacement treatment for patients with ESRD,
including maintenance dialysis and transplantation, has posed large
economic burdens on patients and the government. Although
awareness of treatment options for many nephrological and
urological diseases has recently improved, most patients undergoing
prostate biopsies in China have exhibited urinary symptoms and
elevated prostate-specific antigen (PSA) levels [5,6]. A cohort study
of a Chinese population found a high rate (46.3–61%) of regional
lymph node involvement or distant metastasis upon initial prostate
cancer diagnosis [6]. However, methods that increase the early
detection and downstaging of prostate cancer, such as PSA
screening and digital rectal examinations, are not routinely used.
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(January 1, 1998–August 31, 2008) in all fields of the Essential
Science Indicators database ranked China’s publication output
fifth in the world [7]; however, scientific publications by Chinese
authors in the fields of nephrology and urology were not reported.
In this study, we thus sought to analyze the contributions of
Chinese authors in three major regions of China - the Mainland
(ML), Hong Kong (HK), and Taiwan (TW) - to research in the
fields of nephrology and urology.
Methods
This retrospective study examined 61 journals related to
nephrology and urology that were selected from the ‘‘urology
and nephrology systems’’ category of the Science Citation Index
Expanded (SCIE) subjects provided by the Institute for Scientific
Information (ISI) [8]. This category included resources for the
diagnosis and treatment of genitourinary and kidney diseases:
general urology and nephrology publications, and specialized
research on the prostate, dialysis and other blood purification
techniques, transplantation, and renal failure. European Urology
Supplements, Pelvi-Perineologie, Revista de Nefrologia Dialisis y Trasplante,
Urologe, and International Urogynecology Journal were not indexed by
Medline and were excluded from this study. Our search of the
PubMed database on April 20, 2008 sought articles published in
the 61 journals (Appendix S1) between January 1999 and
December 2008 by researchers from ML, TW, and HK [9].
The ISSN (print) numbers of the journals (Appendix S1) were used
to perform this search. Research output from the three regions of
China was identified using the first author’s institutional affiliations
(ad). Original clinical trials (including cross-sectional and prospec-
tive cohort studies), randomized controlled trials (RCT), and case
reports were compiled using the publication type categories of the
PubMed database.
Three methods were used to compare publication quality.
First, the accumulated and average IFs were determined using
the ISI’s 2007 Journal Citation Reports (JCR) [10]. Second, we
quantified citations of articles written by researchers affiliated
with Chinese institutions. Third, we identified relevant articles
published in the leading general-medicine journals [The New
England Journal of Medicine (NEJM), Journal of the American Medical
Association (JAMA), The Lancet, British Medical Journal (BMJ), and
Annals of Internal Medicine (AIM)]. Articles related to nephrology
and urology were first extracted independently by two reviewers
(J Xu and LH Hu), and any disagreement between the reviewers
was resolved by viewing the titles, abstracts, and full text if
necessary. The number of articles published by each region in the
top 10 high-impact nephrology and urology journals was also
compared. We determined the 10 most popular nephrology and
urology journals containing articles from the three regions of
China according to the number of such articles published by each
journal.
Statistical analyses
Statistical analyses were performed using STATA 8.0 software
(StataCorp LP, College Station, Texas, US) [11]. Count data are
summarized in the Tables and Figures. Trends in the quantity of
publication output from the three regions were analyzed using
curvilinear regression. The Kruskal-Wallis test was used to detect
differences among the three regions, and rank-sum tests were
conducted between pairs of regions when necessary. Significance
was determined with two-tailed tests and P values of less than 0.05
were considered significant.
Results
Total number of articles
A total of 101,632 articles were published in the 61 journals from
1999 to 2008; 2839 (2.8%) of these were from ML (963/2839,
33.9%), HK (512/2839, 18.1%), and TW (1364/2839, 48.0%). The
annual number of published articles in the fields of nephrology and
urology increased significantly from 1999 to 2008 in the three
regions (ML: 17 to 300, r=0.947, P,0.0001; HK: 33 to 61,
r=0.890,P=0.001; TW: 59 to 230, r=0.929, P,0 . 0 0 0 1 ;F i g .1 ) .
The number of articles from ML has exceeded that from HK since
2004, and surpassed that from TW in 2008. The share of articles
increased significantly over time in ML (r=0.899, P,0.0001) and
TW(r=0.707,P=0.002),butnotinHK(r=0.270,P=0.12;Fig.2).
Clinical trials, randomized controlled trials, and case
reports
The total quantity of published RCTs did not differ among the
three regions (P=0.467). The annual number of published RCTs
from ML has exceeded those from HK and TW since 2007, and
surpassed the combined total of RCTs from HK and TW in 2008.
However, researchers from TW published more clinical trials than
those from ML or HK (ML vs. TW, P=0.044; HK vs. TW,
P=0.010). Researchers from TW published 356 case reports
between 1999 and 2008,which far exceeded thosefromML (n=50,
P,0.001) and HK (n=80, P,0.001). The numbers of case reports
from ML and HK did not differ significantly (P=0.863; Fig. 3).
Impact factors
According to the JCR, 55 nephrology and urology journals had
IF in 2007 [10]. Six journals included in our study had no IF. After
excluding these journals, we found that the accumulated IF of
articles from TW (3620.7) were much higher than those of articles
from ML (2272.9) and HK (1589.2, P=0.008). However, articles
from HK had the highest average IF (3.2), followed by TW (2.7)
and ML (2.3; P,0.001; Table 1).
Citations of articles published in nephrology and urology
journals
In this analysis, publications from TW were most frequently
cited (8725 citations, 1747 articles), followed by those from HK
(5418 citations, 700 articles) and ML (5215 citations, 1680
articles). These differences among the three regions were not
significant (P=0.511; Fig. 4).
High-impact nephrology and urology journals and
leading general-medicine journals
A total of 788 articles from the three regions of China were
published in the 10 top-ranking nephrology and urology journals.
Among them, 17.4% (137/788) were in the top three journals:
Journal oftheAmerican SocietyofNephrology,Journal ofSexual Medicine,an d
European Urology. Researchers from TW published 398 articles in 10
high-impact nephrology and urology journals, those from HK
published 203, and those from ML published 187 articles (Table 2).
A total of 263 articles written by Chinese scholars (ML: n=66,
TW: n=68, HK: n=129) were published in the five leading
general-medicine journals: NEJM, The Lancet, JAMA, BMJ, and
AIM. The two reviewers placed seven of these in the fields of
nephrology and urology. HK (RCT: 2, cross-sectional study: 1;
BMJ:1 ,AIM:1 ,NEJM: 1) and TW (RCT: 2, prospective cohort
study: 1; Lancet:1 ,NEJM:1 ,AIM: 1) produced the same number of
articles, whereas researchers from ML published only one RCT in
NEJM.
Nephrology Articles from China
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The journals that published the most articles written by Chinese
researchers from the three regions are listed in Table 3. For
nephrology, Kidney International contained the most articles from ML,
American Journal of Kidney Diseases published the most from TW, and
Nephrology Dialysis Transplantation contained the most articles from HK.
Kidney International, Nephrology Dialysis Transplantation, Journal of Urology,
and Nephrology appeared among the top 10 journals for all three regions.
Discussion
Nephrology and urology have been practiced in China since the
late 1950s, and have developed rapidly since their integration with
the international community in the mid-1980s [12]. To our
knowledge, this is the first report to assess the contribution of
Chinese authors from the major regions of China to nephrological
and urological research. The results of the present study clearly
Figure 1. Trends in annual numbers of articles published by researchers from the Mainland (ML), Hong Kong (HK), and Taiwan (TW)
from 1999 to 2008.
doi:10.1371/journal.pone.0014781.g001
Figure 2. Annual proportion of journal articles in the global literature written by researchers from the Mainland (ML), Taiwan (TW),
and Hong Kong (HK) from 1999 to 2008.
doi:10.1371/journal.pone.0014781.g002
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periodicals increased dramatically during the study period; the
number of articles from ML has exceeded that from HK since
2004 and surpassed that from TW in 2008.
As two of the most developed autonomous regions in China,
HK and TW have been in the forefront of global scientific
research for many years. Researchers in these regions have
contributed some of the best nephrological and urological studies
to the global literature [13,14]. Our comparison of publication
quality using IF, citation reports, and number of articles published
in leading general-medicine journals demonstrated that the gap
between ML and the other two regions (HK, TW) remained
considerable at the end of the study period (Table 1, Fig. 4).
Articles from HK had the highest average IF, followed by those
from TW and ML; articles from TW were cited most, those from
HK were cited second-most often, and those from ML were cited
the least, although these differences were not significant.
Researchers from TW and HK also published more papers in
high-impact nephrology and urology journals and leading general-
medicine journals than those from ML.
A major reason for this disparity among regions is the limited
nature of medical resources that must serve a large population
across a broad territory in ML, which has restricted the
advancement of scientific research. The disparity between urban
and vast rural areas has made it difficult for the government to
ensure basic health-care services, leaving few resources available
for scientific research [15]. In 2002, nearly 1550 pmp in TW
received regular dialysis treatment; this prevalence was higher
than that in the United States. In the same year, 550 pmp in HK
and only 30 pmp in ML received such treatment [16].
Another factor likely affecting the distribution of our results is
the use of English as the language of publication for most medical
and scientific publications that reach an international audience.
Because English has only become widespread in ML since the
reform and opening-up policies were initiated in 1978, a
substantial amount of high-quality work conducted by ML
researchers has been published in Chinese [1].
Although the total numbers of published RCTs did not differ
among the three regions, the annual number of such studies from
researchers in ML has exceeded those from researchers in TW or
HK since 2007, surpassing the combined total of TW and HK in
2008. Clinical research in ML has thus proceeded at a relatively
rapid pace, due in part to the compliance of patients and the
relatively low cost of the trials conducted. Like many other
developing countries, China has experienced dramatic demo-
graphic and epidemiological transitions. The major health threats
in China’s increasingly urbanized and elderly population are
chronic diseases, which currently account for more than 75% of all
deaths. The prevalence and burden of chronic disease will likely
Figure 3. Number of clinical trials, randomized controlled trials (RCT), and case reports published by researchers from the Mainland
(ML), Hong Kong (HK), and Taiwan (TW) from 1999 to 2008.
doi:10.1371/journal.pone.0014781.g003
Table 1. The accumulated and average impact factors of
articles published in nephrology and urology journals by
researchers from the Mainland (ML), Hong Kong (HK), and
Taiwan (TW) from 1999 to 2008.
Year Accumulated impact factor Average impact factor
ML HK TW ML HK TW
1999 37.0 112.4 177.8 2.2 3.4 3.0
2000 60.0 101.7 220.6 2.1 3.2 2.9
2001 77.9 161.1 341.8 2.0 3.7 2.9
2002 60.3 116.9 266.4 2.1 3.6 2.6
2003 110.5 163.6 305.4 2.5 3.5 2.3
2004 137.3 149.9 346.6 2.4 3.1 2.5
2005 236.7 175.6 332.8 2.5 2.8 2.6
2006 401.5 222.7 455.5 2.5 3.1 2.6
2007 459.7 213.0 566.9 2.4 2.6 2.7
2008 691.9 172.3 606.8 2.3 2.8 2.6
Total 2272.9 1589.2 3620.7 2.3 3.2 2.7
doi:10.1371/journal.pone.0014781.t001
Nephrology Articles from China
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prioritize multicenter prospective studies and RCTs that target the
risk factors, prevention, and treatment of kidney and genitourinary
diseases [17].
The articles included in this study were retrieved from the
computer-generated PubMed search system, which is a compre-
hensive database of articles published in high-quality medical
journals that is administered by the United States’ National Center
for Biotechnology Information (NCBI) at the National Library of
Medicine in Bethesda, Maryland. This study also used data from
the JCR, published by the ISI since 1975. This resource is the
most comprehensive citation index for scientific literature,
covering more than 6000 journals in 2006. Although IF are not
an appropriate measure of the scientific quality of individual
articles, they are widely accepted as a tool for the comparative
evaluation of article sets [18].
Because our study assessed the contribution of Chinese scholars
to the international literature, it may address some inherent
limitations of research reporting in this literature. First, the
journals in our sample were selected from the urology and
nephrology category of the SCIE, but some relevant journals were
not included in this index. In addition, we limited the author’s
affiliation to regional terms (China, HK, TW), thus likely omitting
articles that only designated particular Chinese cities or provinces.
Moreover, our previous study design included the term ‘‘Macau,’’
which was later excluded due to the paucity of affiliated articles.
Figure 4. Annual citations of articles published in nephrology and urology journals by researchers from the Mainland (ML), Hong
Kong (HK), and Taiwan (TW) from 1999 to 2008.
doi:10.1371/journal.pone.0014781.g004
Table 2. Articles published in the 10 highest-impact nephrology and urology journals by researchers from the Mainland (ML),
Hong Kong (HK), and Taiwan (TW) from 1999 to 2008.
Rank Journal 2007 IF ML (%) HK (%) TW (%) Total
1 Journal of the American Society of Nephrology 7.1 21 (27) 30 (38) 27 (35) 78
2 Journal of Sexual Medicine 6.2 5 (38) 1 (8) 7 (54) 13
3 European Urology 5.6 20 (43) 2 (4) 24 (52) 46
4 Kidney International 4.9 54 (28) 45 (23) 94 (49) 193
5 Nature Clinical Practice Nephrology 4.8 1 (10) 8 (80) 1 (10) 10
6 American Journal of Physiology-Renal Physiology 4.4 9 (23) 5 (13) 25 (64) 39
7 Current Opinion in Nephrology and Hypertension 4.1 1 (50) 1 (50) 0 (0) 2
8 Journal of Urology 4.0 45 (24) 16 (9) 126 (67) 187
9 American Journal of Kidney Diseases 4.0 14 (8) 81 (46) 82 (46) 177
10 Prostate 3.7 17 (40) 14 (33) 12 (28) 43
Total 187 (24) 203 (26) 398 (51) 788
doi:10.1371/journal.pone.0014781.t002
Nephrology Articles from China
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regional terms was sufficient to accurately represent nephrological
and urological research in the whole of China.
In conclusion, the number of articles published in the fields of
nephrology and urology by researchers from the three major
regions of China (ML, TW, and HK) all increased significantly
from 1999 to 2008. Although the annual number of publications
written by ML researchers exceeded those of TW and HK in
2008, the quality of these articles needs to be improved. More
prospective studies and RCTs that focus on disease control and
prevention should be conducted in ML.
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Table 3. The 10 nephrology and urology journals publishing
the most articles written by researchers from Mainland China
(ML), Hong Kong (HK), and Taiwan (TW).
Rank ML (n=624) N HK (n=379) N TW (n=836) N
1 AJA 233 AJKD 81 Urology 158
2 KI 54 PDI 77 NDT 155
3 NDT 52 NDT 60 JU 126
4 Urology 50 KI 45 RF 118
5 AJN 48 JASN 30 KI 94
6 BJUI 45 Nephrology 26 UI 59
7 JU 45 BJUI 19 Nephrology 35
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AJA, Asian Journal of Andrology, IF=1.6; KI, Kidney International, IF=4.9; NDT,
Nephrology Dialysis Transplantation, IF=3.2; AJN, American Journal of
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Nephrology, IF=1.9; Urology, IF=0.8; Nephrology, IF=1.2; Prostate, IF=3.7.
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